What's new

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

May 12, 2025 - 13:19
 0
Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril ma...

Next Article

IVF Media G5 - Procedural steps and scientific information after initial consult...

Related Posts

PSUSA/00010571/202407

PSUSA/00010571/202407

May 12, 2025  0

Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

PSUSA/00000761/202408

PSUSA/00000761/202408

May 6, 2025  0